SCHEMBL9255037

SCHEMBL9255037

COc1ccc(C(=O)N2CCN(C(=S)SC)CC2)c(OC)c1OC

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
HTT P42858 3/20 0.49
POLB P06746 1/20 0.49
LMNA P02545 5/20 0.47
GAA P10253 4/20 0.47
HPGD P15428 2/20 0.45
TSHR P16473 1/20 0.45
KDM4E B2RXH2 3/20 0.44
NPSR1 Q6W5P4 1/20 0.43
HIF1A Q16665 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
GFER P55789 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MAPT P10636 1/20 0.42
CYP1A2 P05177 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10459921 0.87 ALDH1A1 (0.68) ALDH1A1L3MBTL1HTTPOLBLMNA
SCHEMBL9249214 0.84 ALDH1A1 (0.43) ALDH1A1L3MBTL1HTTGAAKDM4E
SCHEMBL9256864 0.79 CYP2C19 (0.52) ALDH1A1HTTKDM4ESMN1; SMN2CYP1A2
SCHEMBL4283460 0.78 ALDH1A1 (0.58) ALDH1A1L3MBTL1HTTPOLBLMNA
SCHEMBL9782499 0.78 ALDH1A1 (0.61) ALDH1A1L3MBTL1HTTPOLBLMNA
Hydrochloric Acid SCHEMBL9621338 0.77 ALDH1A1 (0.60) ALDH1A1L3MBTL1HTTPOLBLMNA
SCHEMBL9252776 0.75 CYP2C19 (0.60) ALDH1A1HTTLMNATSHRKDM4E
Hydrochloric Acid SCHEMBL9249587 0.74 CYP2C19 (0.59) ALDH1A1HTTLMNATSHRKDM4E
Hydrochloric Acid SCHEMBL15303081 0.74 ALDH1A1 (0.54) ALDH1A1L3MBTL1HTTPOLBLMNA
SCHEMBL15307480 0.73 ALDH1A1 (0.56) ALDH1A1L3MBTL1HTTPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5446146-A Treatment of liver disorders NIPPON CHEMIPHAR CO., LTD. (JP) 1995-08-29 US disclosed
EP-0326379-B1 Therapeutic agent for liver disease and piperazine derivatives NIPPON CHEMIPHAR CO (JP) 1994-06-01 EP disclosed
US-5070089-A INHIBITION OF LIPID PEROXIDATION NIPPON CHEMIPHAR CO., LTD. (JP) 1991-12-03 US disclosed
EP-0326379-A2 Therapeutic agent for liver disease and piperazine derivatives NIPPON CHEMIPHAR CO., LTD. (JP) 1989-08-02 EP disclosed